I recently spoke with Michael May, President and Chief Executive Officer of CCRM, a Canadian not-for-profit that develops technologies and launches new companies by supporting both academic and industry activities in the field of regenerative medicine, including cell and gene therapy. Our conversation focused on the intersection of medical devices in Regenerative Medicine.
Posts tagged with
1 projects are tagged with “regenerative medicine”.
Dr. Stephanie Willerth is the Acting Director of the Biomedical Engineering program and the Centre for Biomedical Research at the University of Victoria, and Member of the International Collaboration on Repair Discoveries (ICORD). We spoke recently about her current research in Regenerative Medicine and collaborations with StarFish Medical.
Chimeric antigen receptor T-cell (CAR-T) therapy is a rising shining star in Regenerative Medicine. Medical devices will be involved in many of the processes involved with CAR-T therapies. From blood collection, to T-cell isolation and activation, modification, expansion and product formulation, preconditioning and finally T-Cell infusion and delivery, there will be an evolution in the […]